Pegylated Interferon
Efficacy of pegylated interferon α 2a and α 2b in patients with genotype 1 chronic hepatitis C: a meta analysis
... to: Pegylated interferon α-2a, Pegylated interferon α-2b, HCV infection, HCV-related chronic hepatitis, treatment of HCV-related chronic hepatitis, Peg-IFNα-2a versus Peg-IFNα-2b in the ...
11
Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a
... IFNβ, interferon beta; M, macrophage; MMP, matrix metalloproteinase; MS, multiple sclerosis; PEG, polyethylene glycol; PEG-IFNβ, pegylated interferon β; TIMP-1, tissue inhibitor of ...
14
Treatment of Hepatitis C with Pegylated Interferon Alpha 2a and Ribavirin: Experience from Benin
... DOI: 10.4236/ojgas.2018.88030 277 Open Journal of Gastroenterology CNHU-HKM in Cotonou. This was a cross-sectional study, retrospective from November 1, 2010 to December 31, 2015 (62 months) and prospective from January ...
9
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
... Given that this modeling study was performed before the current era of direct-acting antiviral (DAA) therap- ies, and DAAs are not currently available in Thailand, our study examined the available standard of care for ...
9
Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review
... defined. Interferon alpha-2b remains to date the most promising approach ...of interferon in its pegylated subcutaneous ...of pegylated interferon alpha-2b in Stage III malignant ...
10
Original Article Depression scores of delta hepatitis patients treated with pegylated interferon alfa
... future, interferon still seems to be the preferred drug in clinical use for the treatment of hepatitis delta, observations on the aforementioned side effect is worth ...with pegylated interferon ...
5
Effects of Host and virus related factors on Interferon α+ribavirin and Pegylated interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
... received pegylated interferon com- pared to non-pegylated ...the pegylated interferon is at least 25 times expensive than non-pegylated interferon therefore is beyond the ...
7
Efficacy of pegylated interferon α2a in patients without HBeAg loss after the withdrawal of long term lamivudine therapy
... of pegylated interferon (PEG- IFN) α has certain advantages over NUCs, which include the absence of resistance, higher rates of HBeAg loss and seroconversion, and higher rates of both sustained ...
9
Pegylated interferon alfa 2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response
... of pegylated-interferon (PEG- IFN) and ribavirin (RBV) for 48 weeks, and this treat- ment results in ~50% sustained virological response (SVR) in patients with HCV genotype 1 and high viral loads ...
6
The effect of pegylated interferon alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
... Tocci G, Boumis E, Noto P, Solmone MC, Capobianchi MR, Girardi E: The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects ...
7
Acute Exacerbation of Liver Disease Induced by Pegylated Interferon Alpha2a Treatment for Chronic Hepatitis C
... The administration of pegylated interferon (Peg-IFN) in combination with ribavirin is currently the first-line op- tion for the treatment of chronic hepatitis. This approach achieves a sustained virological ...
5
<p>Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B</p>
... Currently, interferon and nucleotide analogs (NUCs) are important antiviral agents for the treatment of CHB ...5,6 Pegylated interferon (Peg-IFN) is recom- mended as fi rst-line therapy in the ...
10
Reactivation of Tuberculosis during Dual Therapy with Pegylated Interferon and Ribavirin for Chronic Hepatitis C about a Case
... endogenous interferon α . This active in CD4 T cells, the gene for interferon-gamma involved in the control of mycobacterial infections ...with pegylated interferon and ribavirin and who ...
5
Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child
... Copyright © 2012 Takeshi Endo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
5
Severe acute exacerbation of chronic hepatitis B during pegylated interferon treatment and early intervention with corticosteroid
... standard interferon- α (IFN- α ) therapy had been reported to occur in few patients with chronic hepatitis ...that pegylated interferon- α therapy was able to induce severe acute exacerbation of ...
6
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non responders to interferon plus ribavirin Is it different in real life?
... Patients who had a decrease of at least 2 log 10 in the viral load obtained SVR of 12%. In our study, 65% of the patients with HCV-genotype 1, with EVR, had SVR. Of the patients infected by HCV-genotype 3, 56% had SVR. ...
7
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
... BIP48: Pegylated interferon alfa-2b; CAV: Absorptiometry; CGEB: Center of genetic engineering and biotechnology; CL: Clearance; Cmax: Maximum concentration; CONEP: National research ethics commission; DAA: ...
8
Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4
... We studied retrospectively the data of 1861 Egyptian patients with chronic hepatitis C who received antiviral therapy (pegylated-interferon alpha plus Ribavirin) at Cairo-Fatemic Hospital, Ministry of ...
6
Naturally Occurring Resistance Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon Ribavirin
... D irect-acting antiviral agents (DAAs) (1) targeting the non- structural 3 (NS3)/4A protease, the NS5A protein, or the NS5B RNA-dependent RNA polymerase of hepatitis C virus (HCV) are increasingly used in the treatment ...
8
Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
... Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response.. Predicting sustained viro[r] ...
13